Evidence map›Paper›PMID 28446616›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective.

Jeffrey M Harder, Catherine E Braine, Pete A Williams, Xianjun Zhu, Katharine H MacNicoll, Gregory L Sousa, Rebecca A Buchanan, Richard S Smith, Richard T Libby, Gareth R Howell and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 116 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Complement in brain and eye disease: shared mechanisms, convergent pathologies, and common therapeutic opportunities.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  5. IL1A enhances TNF-induced retinal ganglion cell death.Frontiers in aging neuroscience · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Role of Microglia in Glaucomatous Pathology.Advances in experimental medicine and biology · 2025
    Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Jeffrey M HarderThe Jackson Laboratory, Bar Harbor, ME 04609.
Catherine E BraineThe Jackson Laboratory, Bar Harbor, ME 04609.
Pete A WilliamsThe Jackson Laboratory, Bar Harbor, ME 04609.
Xianjun ZhuHoward Hughes Medical Institute, The Jackson Laboratory, Bar Harbor, ME 04609.
Katharine H MacNicollThe Jackson Laboratory, Bar Harbor, ME 04609.
Gregory L SousaThe Jackson Laboratory, Bar Harbor, ME 04609.
Rebecca A BuchananThe Jackson Laboratory, Bar Harbor, ME 04609.
Richard S SmithThe Jackson Laboratory, Bar Harbor, ME 04609.
Richard T LibbyFlaum Eye Institute, University of Rochester Medical Center, Rochester, NY 14642.ORCID 0000-0003-2844-7632
Gareth R HowellThe Jackson Laboratory, Bar Harbor, ME 04609; gareth.howell@jax.org simon.john@jax.org.
Simon W M JohnThe Jackson Laboratory, Bar Harbor, ME 04609.
Jackson Laboratory · USHoward Hughes Medical Institute · USTufts University · USUniversity of Rochester Medical Center · US

Funding

Factors Determining Intraocular Pressure and Glaucoma SusceptibilityR01EY011721 · NEI · JACKSON LABORATORY · PI JOHN, SIMON W · 2002 to 2018
$12.4M
Cell Death Pathways in Glaucomatous NeurodegenerationR01EY018606 · NEI · UNIVERSITY OF ROCHESTER · PI JOHN, SIMON W, LIBBY, RICHARD T · 2008 to 2023
$5.8M
Investigating Cell Specific Roles of the Complement Cascade in GlaucomaR01EY021525 · NEI · JACKSON LABORATORY · PI HOWELL, GARETH R · 2012 to 2016
$2.5M
FACTORS DETERMINING INTRAOCULAR PRESSURER29EY011721 · NEI · JACKSON LABORATORY · PI JOHN, SIMON W · 1997 to 2001
$227k
Howard Hughes Medical InstituteNEI NIH HHS R01 EY011721NEI NIH HHS R01 EY018606NEI NIH HHS R01 EY021525NEI NIH HHS R29 EY011721
6 · The paper itself

Abstract

Various immune response pathways are altered during early, predegenerative stages of glaucoma; however, whether the early immune responses occur secondarily to or independently of neuronal dysfunction is unclear. To investigate this relationship, we used the

Indexed as

AnimalsComplement C3ErbB ReceptorsGlaucomaIntraocular PressureMiceMice, Inbred DBAMice, KnockoutOptic NerveQuinazolinesRetinal Ganglion CellsSignal TransductionTyrphostinsUp-RegulationComplement C3EGFR protein, mouseErbB ReceptorsQuinazolinesRTKI cpdTyrphostinsastrocytescomplementEGFRglaucomaWLDS

Identifiers

PMID28446616
PMCPMC5441748
OpenAlexW2607574901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.